News

KCR has opened new offices in London and Berlin, and is now turning its attention to France.

Despite a slight boost in funding for the Food and Drug Administration and stronger tax incentives for investment in R&D, significant changes in Medicare drug reimbursement and coverage policies have biopharmaceutical companies up in arms.

Celerion is pleased to announce the expansion of clinical operations to South Korea.

Celerion will expand clinical operations to South Korea.

Expanded membership and new process to prequalify providers among 2014 priorities.

The Avoca Quality Consortium announced its key initiatives for 2014.

DIA Exhibitor Form 2014

Proteomics International Partners with inVentiv Health Clinical

EMA's Executive Director, Guido Rasi received the 2014 European Rare Disease Leadership Award 2014.

Dennis Gillings, PhD, Executive Chairman of Quintiles, has been appointed the first world dementia envoy.

Novartis has renewed its commitment to clinical trial data transparency

Experienced leaders form Provision Research Compliance Services, a joint venture between Schulman Associates IRB, Inc. and Falcon Consulting Group, LLC

Organizations involved in clinical trials have embraced the idea that they should collect performance measures to assess how well they conduct clinical trials.

...a panel discussion was held with CEOs of top generic pharmaceutical companies and key financial analysts.

Would you delay protocol approval by two months if it meant your enrollment and retention would improve and, in turn, positively affect your data quality?

A panel discussion was held with CEOs of top generic pharmaceutical companies and key financial analysts...

Schulman Associates IRB, Inc. and Falcon Consulting Group, LLC announced they have formed a joint venture

Ipsen will be standardizing its content management on Veeva Systems' Veeva Vault

Top pharmaceutical company selects Veeva Vault in enterprise initiative to transform IT and empower the business

Speed, efficiency, and accuracy are vital to the success of clinical trials.

Cardialysis selected AG Mednet as its preferred provider for image data submission and collection.

A new report released by GlobalData projects a modest increase in the global schizophrenia treatment market value

The analysis of patterns in clinical trials has indicated that studies are becoming increasingly complex.

Addressing client demand to ease the transition between clinical and commercial launch for blister products...

The global schizophrenia treatment market value is expected to undergo a modest increase over the coming decade...

Patients communicated alarming behaviors clearly attributed to a lack of communications and engagement from study teams.

Almac announced they have added new blistering technology at their?US commercial packaging facility?in Audubon, PA.

Provides industry leading insights leveraging clinical, financial and operational data